Anthropic Adds Novartis CEO Vas Narasimhan to Board of Directors
Anthropic, the AI company behind Claude, announced that Vas Narasimhan has joined its board. Narasimhan serves as CEO of Novartis. The board also includes Netflix co-founder Reed Hastings and former White House deputy chief of staff Chris Liddell.
Jim.henderson / Wikimedia (CC BY-SA 4.0)Anthropic Announces New Board Member Anthropic announced that Vas Narasimhan has joined its board.
The announcement came via Anthropic on April 15, 2026. Narasimhan is the CEO of Novartis. Anthropic is the AI company behind Claude. The addition of Narasimhan expands the board, which includes Reed Hastings, the co-founder of Netflix, and Chris Liddell, the former White House deputy chief of staff in the first Trump administration.
@statnews reported the details of the board appointment.
Background on Anthropic's Board Composition Reed Hastings serves as a member of Anthropic's board.
Hastings co-founded Netflix. His involvement provides continuity to the board's structure. Chris Liddell is another member of Anthropic's board. Liddell held the position of White House deputy chief of staff in the first Trump administration.
The board's composition reflects diverse professional backgrounds. Anthropic develops AI technologies, including the Claude model. The company's board oversees strategic decisions related to its operations.
Details of the Appointment Vas Narasimhan's role on the board follows the announcement from Anthropic.
As CEO of Novartis, Narasimhan brings experience from the pharmaceutical sector. The appointment strengthens Anthropic's governance with expertise in life sciences. The facts of the board membership are verified through Anthropic's statement.
No additional changes to the board were specified in the announcement. @statnews reported on the event based on these details.
Story Timeline
5 events- 2026-04-15
Anthropic announced Vas Narasimhan joined its board.
1 sourceAnthropic - Prior to 2026
Reed Hastings, Netflix co-founder, serves as Anthropic board member.
1 sourceunattributed - Prior to 2026
Chris Liddell, former White House deputy chief of staff, serves as Anthropic board member.
1 sourceunattributed - Ongoing
Vas Narasimhan serves as CEO of Novartis.
1 sourceunattributed - Ongoing
Anthropic operates as AI company behind Claude.
1 sourceunattributed
Potential Impact
- 01
Strengthened governance at Anthropic with diverse industry representation
- 02
Anthropic gains pharmaceutical expertise on board through Narasimhan's Novartis background
- 03
Potential for AI applications in drug development via board collaboration
- 04
Novartis may explore AI partnerships influenced by Narasimhan's role
Transparency Panel
Related Stories
StatFDA Sends Reminder Letters to Over 2,200 Companies and Researchers on Clinical Trial Reporting
The Food and Drug Administration sent reminder letters to more than 2,200 companies and researchers, informing them of the requirement to report clinical trial results to a federal database or face fines. The letters target entities associated with over 3,000 registered trials, s…
Sebastian Ballard / Wikimedia (CC BY-SA 2.0)Hospital Admissions for Spider Bites Increase in England Over Past Decade
NHS figures show hospital admissions linked to spider bites in England rose from 47 in 2015 to 100 in 2025. Experts attribute the trend to the growing population of noble false widow spiders. The spiders are not aggressive and have not caused serious illness or death, though bite…
StatSTAT Publishes Reader Responses on Nutrition Education and Emergency Room Challenges in Healthcare
STAT News featured letters to the editor responding to articles on nutrition education in medical schools and emergency room conditions. Contributors addressed social determinants of health, the need for interdisciplinary collaboration, and risks to vulnerable patients in ER hall…